Late cardiovascular effects of Cancer Therapy (in Childhood

Registration form March 3rd-4th 2016
Meeting attendance:
March 3rd March 4th
Adress:
Local Faculty:
• Prof. Dr. med. Dr. h.c. Gerd Heusch
Institute for Pathophysiology
• PD Dr. med. Hagen Kälsch
Clinic of Cardiology
• Dr. med. Christos Rammos
Clinic of Cardiology
• Prof. Dr. med. Tienush Rassaf
Clinic of Cardiology (Westdt. Herz-und Gefäßzentrum WDHGZ)
• Prof. Dr. med. Achim Schmaltz
(Secretary German Society of Pediatric Cardiology - DGPK)
• Prof. Prof. h. c. Dr. med. Martin Schneider
(Deutsches Kinderherzzentrum, St. Augustin)
Office:
Pediatrics III | Cardiology
Ute Kruse
University Hospital Essen
Hufelandstraße 55, 45122 Essen
Fon: 0201-723 3269
Fax: 0201-723 5983
E-mail: [email protected]
Organizer:
• University Hospital Essen
Pediatrics III
Prof. Dr. med. Dirk Reinhardt
Dr. med. Ulrich Neudorf
• Zentrum für Forschungsförderung in der Pädiatrie GmbH
Katharina Waack
Certification:
Submitted by Ärztekammer Nordrhein.
Venue:
University Hospital Essen
Administrative building, lecture room 2. floor
Hufelandstraße 55
45147 Essen
Late cardiovascular effects
of Cancer Therapy
(in Childhood)
© 2015 | Freund | Pediatrics III
Please inform us if you will participate in the meeting by returning the attached registration form until February 12th 2016 by:
fax +49 (0)201 723 5983 or
mail [email protected].
Workshop
March 3rd - 4th 2016
Program
Dear members,
Thursday March 3rd 2016 • 9:00 h – 17:30 h
therapy of cancer in children is a story of great success,
because many patients will survive the disease.
So longterm effects of therapy will be of major concern in
the future. Our aim is, to bring people together who deal
with this problem and to find a consens between oncologists and cardiologists.
We invited speakers working in this field and are looking
forward to an intensive discussion with you.
Prof. Dr. Dirk Reinhardt
Dr. Ulrich Neudorf
Welcome
Prof. Dr. med. Dirk Reinhardt
Introduction
Cardiac long-term problems – view of the pediatric cardiologist
Prof. Dr. med. Jochen Weil
CVSS Study-Group
Dr. med. Arthur Wingerter
LESS-Study Group
Prof. Dr. med. Thorsten Langer
Research net pediatric Cardiology
Prof. Dr. med. Hashim Abdul-Khaliq
Round Table, summary and closing remarks
Cardiac long-term problems – view of the pediatric oncologist
Prof. Dr. med. Thorsten Langer
Cardiovascular disease in adult survivors of childhood cancer
Prof. Dr. med. Steven Lipshultz
Cardiotoxicity in AML
Prof. Dr. med. Ursula Creutzig
Speakers
Miscellaneous - pulmonary vessels, cardiovascular risk
Dr. med. Ulrich Neudorf
• Prof. Dr. med. Hashim Abdul-Khaliq
Päd. Kardiologie, Universitätsklinikum des Saarlandes
Pathophysiology and therapeutic approaches
• Prof. Ursula Creutzig
Medizinische Hochschule Hannover
Doxorubicin-CMP: mechanisms and therapeutic targets
Prof. Dr. med. Steven Lipshultz
Role of biomarkers
NN
Basic Research
PD Dr. rer. nat. Petra Kleinbongard
Friday March 4th 2016 • 9:00 h – 15:30 h
Imaging
Role of echocardiographic tools – what is necessary, possible – limitations, future
Dr. med. Amir-Abbas Mahabadi
* Sponsoring by Actelion
Efforts for the future
Role of MRI tools – what is necessary, possible – limitations, future
Prof. Dr. med. Thomas Schlosser
• PD Dr. rer. nat. Petra Kleinbongard
Institut für Pathophysiologie, Universitätsklinikum Essen
• Prof. Dr. med. Thorsten Langer
Pädiatrische Onkologie & Hämatologie, Universität Lübeck
• Prof. Dr. med. Steven Lipshultz
Children‘s Hospital of Michigan, Detroit, USA
• Dr. med. Amir-Abbas Mahabadi
Klinik für Kardiologie, Universitätsklinikum Essen
• Prof. Dr. med. Thomas Schlosser
Institut für Radiologie, Universitätsklinikum Essen
• Prof. Dr. med. Jochen Weil
Deutsches Herzzentrum, München
• Dr. med. Arthur Wingerter
Kinder- und Jugendmedizin, Universitätsmedizin Mainz